Abstract:Background:: Medical devices are the machine, tool, instrument, apparatus, implant, calibrator in vitro, software, the similar or related object intended for use by the manufacturer alone or in combination becoming increasingly important in the healthcare sector as these are used to diagnosis, control, prevention or treatment of an illness. Safety of the world population is the highest priority in order to launch new medical devices for the treatment and diagnostic of several diseases. New innovation in industries and regulations work together to provide devices for different world market and to improve quality and safety of exiting devices in the market. The main key for devices is to classify the determination of actual regulatory pathway which ensures the safety standards and other regulatory requirements in a specific country. We perform clinical trials for medical device which are quite different from the clinical trials performed for drug analysis. For any high-risk devices, the new EU law states that the manufacturer has to prepare a complete summary for their evidence. The clinical trials regulation provides more transparency on clinical trials data. Complete transparency is required for the maximum possibility of informed decisions in order to use new medical devices. Objective:: The current manuscript will provide the information regarding the regulatory framework for the approval of medical devices and clinical investigation of medical device in European Union and comparison of approval process of medical device in USA, EU and India. The aim of this paper is to provide an overview of the most suitable and emerging requirements that manufacturers need for introducing their medical devices in the market in compliance with the MDR regulations. Conclusion:: The proposal for a modified regulation of medical devices aims to ensure more robust clinical data in support of the CE marking applications of the medical device. The clinical investigation requirements will be mandatory, and there will be an obligation to demonstrate the clinical benefits of the device and provide a rigorous equivalence test if the assessment is based on comparison devices. The new European legislation should require the premarket demonstration of clinical efficacy and safety, using a randomized controlled trial if possible, and a transparent clinical review, preferably centralized.

EXPORT REGISTRATION OF PHARMACEUTICALS IN REST OF WORLD COUNTRIES (ROW)

OVERVIEW OF DRUG REGISTRATION REQUIREMENTS FOR PHARMACEUTICALS IN EMERGING MARKET

COMPARISON OF REGISTRATION PROCESS OF NUTRACEUTICALS AND HERBAL SUPPLEMENTS IN INDIA, US AND EUROPE

STUDY OF MULTISOURCE MEDICINAL PRODUCT REGISTRATION PROCEDURE OF MARKETING AUTHORIZATION IN ASEAN (SINGAPORE)

A comprehensive review on registration requirements for Drug Approval in India, South Africa and US

Analysis of regulatory requirements of medical devices and in-vitro diagnostics worldwide for the development of an efficient procedure of registration for manufacturers of medical products

A Review of Registration and Approval Process of Medical Device in India and Japan

A Review of Regulatory Mechanisms Used by the WHO, EU, and US to Facilitate Access to Quality Medicinal Products in Developing Countries With Constrained Regulatory Capacities

Industrial prospects on regulatory gaps and barriers in pharmaceutical exports and their counteraction: Local experiential with global implication

New Drug Approval Process In Singapore - A Detailed Dissertation For Registration of Multi - Source Drug Products

Indian Pharmaceutical Industries Current Status and Togetherness to Overcome Speed Breakers in Term of Quality Issues to make India as a Global Pharma Destination

Regulatory Trends in Drug Development in Asia Pacific

Current regulations of Herbal medicines in the US and EU

Regulatory requirements for the approval of Anti-Cancer drug (Mercaptopurine) in Myanmar as per ACTD

Multi-regional clinical trials and global drug development

Regulatory perspectives on medical device approval in global jurisdictions

Regulations for Health Care Biotechnology Products in Major Markets of the World

CURRENT STATUS AND CHALLENGES OF HERBAL DRUG DEVELOPMENT AND REGULATORY ASPECT: A GLOBAL PERSPECTIVE

Challenges and prospects in Chinese pharmaceutical regulatory environment

Regulation and Clinical Investigation of Medical Device in the European Union

Navigating the regulatory landscape: A comprehensive analysis of regulatory affairs in the pharmaceutical industry